Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8694

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagram of venlafaxine hydrochloride showing its molecular configuration with labeled atoms including a methoxybenzene ring and an ethanolamine side chain, alongside the hydrochloride component.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic (PK) parameters including Cmax and AUC of venlafaxine and its metabolite ODV across various special populations. Populations include hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents the change relative to a reference value.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
This figure is a forest plot showing the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The plot presents changes relative to the reference value for each interaction.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
A forest plot chart illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes in interaction with different drugs. The x-axis shows the change relative to a reference value, ranging from 0 to 3. Each drug is listed alongside its analytes and pharmacokinetic metrics with plotted points and error bars indicating variability.*
FDA Label Image

Venlafaxine HCl Extended-release Capsules 75mg (Strength 2 30ct)

Venlafaxine HCl Extended-release Capsules 75mg (Strength 2 30ct)
Label for Venlafaxine Hydrochloride Extended-Release Capsules 75 mg, generic for Effexor ER. The label shows the product name, strength, dosage form, and manufacturer Yichang Humanwell Oral Solid Dosage Plant. It includes storage instructions and a caution statement about federal law. The capsule is described as orange and gray, imprinted with YH 129.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.